Adila Izgutdina

6PUBLICATIONS
35CO-AUTHORS
Molecular targetsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Dec 30, 2025
Affinity-matured CD72-targeting nanobody CAR T cells enhance elimination of antigen-low B-cell malignancies.

Adila Izgutdina, Tasfia Rashid, William C Temple

|Sep 26, 2025
Bicistronic CAR T-cells Against CD70 & Active Integrin β2 Overcome Antigen Heterogeneity and Preserve Safety in Acute Myeloid Leukemia.

Amrik S Kang, Haley Johnson, Nicole Lei

|Jun 04, 2025
Affinity-matured CD72-targeting Nanobody CAR T-cells Enhance Elimination of Antigen-Low B-cell Malignancies.

Adila Izgutdina, Tasfia Rashid, William C Temple

|May 13, 2025
Targeting high-risk multiple myeloma genotypes with optimized anti-CD70 CAR T cells.

Corynn Kasap, Adila Izgutdina, Bonell Patiño-Escobar

|Apr 23, 2025
Cellular immunotherapy targeting CLL-1 for juvenile myelomonocytic leukemia.

Juwita Werner, Alex G Lee, Chujing Zhang

|Oct 31, 2023
Structural surfaceomics reveals an AML-specific conformation of integrin β2 as a CAR T cellular therapy target.

Kamal Mandal, Gianina Wicaksono, Clinton Yu

Pageof 1

Frequent Collaborators

6 joint publications

Arun Wiita

3 joint publications

Bonell Patiño-Escobar

3 joint publications

Elliot Stieglitz

2 joint publications

Amrik Singh Kang